PENTAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pentam, and what generic alternatives are available?
Pentam is a drug marketed by Fresenius Kabi Usa, Pai Holdings, X-gen Pharms Inc, Avet Lifesciences, Baxter Hlthcare, Hospira, Pharmobedient, and Watson Labs. and is included in nine NDAs.
The generic ingredient in PENTAM is pentamidine isethionate. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentam
A generic version of PENTAM was approved as pentamidine isethionate by PAI HOLDINGS on September 28th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENTAM?
- What are the global sales for PENTAM?
- What is Average Wholesale Price for PENTAM?
Summary for PENTAM
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,146 |
| Drug Prices: | Drug price information for PENTAM |
| DailyMed Link: | PENTAM at DailyMed |
Recent Clinical Trials for PENTAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Illinois at Chicago |
Pharmacology for PENTAM
| Drug Class | Antiprotozoal |
US Patents and Regulatory Information for PENTAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | PENTAM | pentamidine isethionate | INJECTABLE;INJECTION | 019264-001 | Oct 16, 1984 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pai Holdings | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 206666-001 | Sep 28, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Avet Lifesciences | PENTAMIDINE ISETHIONATE | pentamidine isethionate | INJECTABLE;INJECTION | 213806-001 | Jan 7, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
